Cumberland Pharmaceuticals Inc. (CPIX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Cumberland Pharmaceutical...

NASDAQ: CPIX · Real-Time Price · USD
3.49
0.02 (0.58%)
At close: Aug 29, 2025, 3:59 PM
3.61
3.44%
After-hours: Aug 29, 2025, 07:06 PM EDT

Cumberland Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
37.87M 39.55M 42.01M 35.99M
Cost of Revenue
6.59M 6.07M 9.12M 8.81M
Gross Profit
31.28M 33.49M 32.89M 27.17M
Operating Income
-6.43M -6.21M -5.7M -7.68M
Interest Income
334.44K 286.85K 98.41K 26.08K
Pretax Income
-6.47M -6.28M -5.58M -5.56M
Net Income
-6.48M -6.28M -5.65M -5.6M
Selling & General & Admin
28.15M 29.1M 26.84M 24.8M
Research & Development
4.82M 5.83M 6.69M 5.68M
Other Expenses
4.75M 8.1M 5.07M 4.37M
Operating Expenses
37.71M 43.04M 38.6M 34.85M
Interest Expense
605.51K 667.86K 586K 98.03K
Selling & Marketing Expenses
17.02M 18.45M 16.66M 15.02M
Cost & Expenses
44.3M 49.11M 47.72M 43.66M
Income Tax Expense
-22.67K 45.77K 68.85K 34.89K
Shares Outstanding (Basic)
14.06M 14.3M 14.56M 14.9M
Shares Outstanding (Diluted)
14.06M 14.3M 14.56M 14.9M
EPS (Basic)
-0.46 -0.44 -0.39 -0.38
EPS (Diluted)
-0.46 -0.44 -0.39 -0.38
EBITDA
182.42K 153.32K 332.92K -857.83K
EBIT
-5.86M -5.62M -5M -5.46M
Depreciation & Amortization
6.04M 5.77M 5.33M 4.61M